Compositions And Methods For Inhibiting Nf-κb And Sod-1 To Treat Amyotrophic Lateral Sclerosis

Abstract

The invention relates to pharmaceutical compositions, kits, methods, and uses for the treatment of amyotrophic lateral sclerosis. In particular, the invention relates to compositions, kits, methods, and uses for the treatment of amyotrophic lateral sclerosis by inhibiting NF-κB in microglia or macrophages and by inhibiting motor neuron death. The invention further relates to compositions, kits, methods, and uses for the treatment of amyotrophic lateral sclerosis by inhibiting NF-κB in microglia in combination with inhibiting SOD-1 in astrocytes. The invention also relates to a method for inhibiting the expression or the activity of NF-κB in microglia or macrophages to inhibit motor neuron death, alone or in combination with inhibiting SOD-1 expression in astrocytes.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 8, 2017
  • Application: Nov 4, 2014
    US US 201415034489 A
  • Priority: Nov 4, 2014
    US US 201415034489 A
  • Priority: Nov 4, 2014
    US US 2014/0063890 W
  • Priority: Nov 5, 2013
    US US 201361900105 P

Download Citation


Sign in to the Lens

Feedback